» Articles » PMID: 6863546

Genetic Heterogeneity in Partial Adenosine Deaminase Deficiency

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1983 Jun 1
PMID 6863546
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Inherited deficiency of the enzyme adenosine deaminase (ADA) results in a syndrome of severe combined immunodeficiency (SCID). Children with ADA- -SCID lack ADA in all cells and tissues. In contrast, a "partial" deficiency of ADA has been described in six immunologically normal children from four different "families." These children lack ADA in their erythrocytes but retain variable amounts of activity in their lymphoid cells. We have examined ADA activity in lymphoid line cells from four of these children, who are unrelated, for evidence of genetic heterogeneity. One child, who is Caucasian, has an enzyme with increased electrophoretic mobility, a diminished isoelectric point (pI 4.8 vs. Nl = 4.9) and very low activity (2.3 vs. Nl = 82.9 +/- 12.9 nmol/mg protein per min); as a second child has an enzyme with normal electrophoretic mobility but increased isoelectric point (pI = 5.0), markedly diminished heat stability at 56 degrees C (t1/2 = 4.2' vs. Nl = 40') and low activity (12.1); a third has an enzyme with only diminished heat stability (t1/2 = 6.5'), no detectable abnormality in charge and almost normal activity (41.9); while the fourth exhibits only diminished ADA activity (25.0) with no striking qualitative abnormalities. Thus, we have found evidence for three different mutations at the structural locus for ADA in three of these individuals, (a) an acidic, low activity heat stable mutation (b) a basic, somewhat higher activity, heat labile mutation, and (c) a relatively normal activity heat labile mutation. In the fourth, there is as yet no compelling evidence for a mutation at the structural locus for ADA and a mutation at a regulatory locus cannot be excluded.

Citing Articles

Adenosine deaminase deficiency: a review.

Flinn A, Gennery A Orphanet J Rare Dis. 2018; 13(1):65.

PMID: 29690908 PMC: 5916829. DOI: 10.1186/s13023-018-0807-5.


Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.

Adrian G, Wiginton D, HUTTON J Hum Genet. 1984; 68(2):169-72.

PMID: 6548726 DOI: 10.1007/BF00279309.


Sequence of human adenosine deaminase cDNA including the coding region and a small intron.

Wiginton D, Adrian G, HUTTON J Nucleic Acids Res. 1984; 12(5):2439-46.

PMID: 6546794 PMC: 318674. DOI: 10.1093/nar/12.5.2439.


Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.

Adrian G, Wiginton D, HUTTON J Mol Cell Biol. 1984; 4(9):1712-7.

PMID: 6208479 PMC: 368977. DOI: 10.1128/mcb.4.9.1712-1717.1984.


Cloning of cDNA sequences of human adenosine deaminase.

Wiginton D, Adrian G, Friedman R, Suttle D, HUTTON J Proc Natl Acad Sci U S A. 1983; 80(24):7481-5.

PMID: 6200875 PMC: 389975. DOI: 10.1073/pnas.80.24.7481.


References
1.
Hopkinson D, Harris H . The investigation of reactive sulphydryls in enzymes and their variants by starch gel electrophoresis. Studies on red cell adenosine deaminase. Ann Hum Genet. 1969; 33(1):81-7. DOI: 10.1111/j.1469-1809.1969.tb01632.x. View

2.
Hopkinson D, Cook P, Harris H . Further data on the adenosine deaminase (ADA) polymprphism and a report of a new phenotype. Ann Hum Genet. 1969; 32(4):361-7. DOI: 10.1111/j.1469-1809.1969.tb00087.x. View

3.
GIBLETT E, Anderson J, Cohen F, POLLARA B, Meuwissen H . Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972; 2(7786):1067-9. DOI: 10.1016/s0140-6736(72)92345-8. View

4.
Jenkins T . Red-blood-cell adenosine deaminase deficiency in a "healthy" Kung individual. Lancet. 1973; 2(7831):736. DOI: 10.1016/s0140-6736(73)92568-3. View

5.
Hirschhorn R, Levytaka V, POLLARA B, Meuwissen H . Evidence for control of several different tissue-specific isozymes of adenosine deaminase by a single genetic locus. Nat New Biol. 1973; 246(155):200-2. DOI: 10.1038/newbio246200a0. View